We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Israeli Researchers Want ImClone To Pay Royalties

Law360 (November 2, 2006, 12:00 AM EST) -- ImClone Systems Inc. should pay restitution and royalties and be required to get a license for its popular cancer drug Erbitux from the true inventors of the drug, an attorney for the inventors said Tuesday in a recent court filing.

An attorney for Yeda Research and Development Company Ltd. filed the claim in the U.S. District Court for the Southern District of New York.

Last month, a federal judge ruled that scientists at biopharmaceutical company ImClone Systems Inc. copied the work of three Israeli researchers defended...
To view the full article, register now.